Skip to content
DraconiticResearch
Search Sources API
190,860 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BYIJTLD open

Trials, tribulations, and formulations in access to new TB drugs for children: learning from rifapentine

  • A.C. Hesseling1
  • N. Salazar-Austin2
  • M. Louey3
  • L. van der Laan1
  • M. Gombe4
  • T. Masini5
  • M. Penazzato6
  • I. Courtney1
  • A. Garcia-Prats1
  • D. Tarlton7
  • M. Frick8
8 affiliations
  1. 1Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa;
  2. 2Department of Pediatrics and Johns Hopkins Bloomberg School of Public Health, Department of International Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA;
  3. 3Clinton Health Access Initiative, New York, NY, USA;
  4. 4The Aurum Institute, Johannesburg, South Africa;
  5. 5Independent Consultant, Lucca, Italy;
  6. 6Global Accelerator for Paediatric Formulations Network, World Health Organization, Geneva, Switzerland;
  7. 7UNITAID, Geneva, Switzerland;
  8. 8Treatment Action Group, New York, NY, USA.
Read full textPDFCite

Related

  1. Therapeutic Equivalence, Immunogenicity, and Safety of Euvichol Oral Cholera Vaccine Formulations Compared with WHO-prequalified Shanchol vaccine in Healthy Children and Adults: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    K. M. Al-Dhayani, Z. A. Hasan, K. B. A. Alastah +2
    bioRxivPreprintCC BYFull textPharmacology & toxicologybioRxiv
  2. Comparative efficacy and safety of dupilumab and swallowed topical corticosteroid formulations in eosinophilic esophagitis : A systematic review and network meta-analysis of randomized controlled trials
    Muhammad Arsalan, FNU Sawaira, Suliman Shah +11
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  3. Uncertainty-aware physics-informed meta-learning for predicting niosomal particle size across formulations and processing conditions
    Ahmad J. Obaidullah, Wael A. Mahdi, Adel Alhowyan
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials
    Rose Gelineau‐Morel, J. Steven Leeder, Jonathan B. Wagner
    Clinical Pharmacology and TherapeuticsPeer-reviewedLicence not statedFull textObstetrics, gynaecology & paediatricsPMC
  5. Associations between behavioral intervention dose and outcomes in children and adolescents with obesity: meta-regression of randomized clinical trials
    Yakun Liu, Xiaoyan Shi, Tingwen Chen +4
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref

Cite

BibTeXRIS
BibTeX
@article{hesseling2026trials,
  title = {{Trials, tribulations, and formulations in access to new TB drugs for children: learning from rifapentine}},
  author = {A.C. Hesseling and N. Salazar-Austin and M. Louey and L. van der Laan and M. Gombe and T. Masini and M. Penazzato and I. Courtney and A. Garcia-Prats and D. Tarlton and M. Frick},
  journal = {IJTLD open},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13657021},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Trials, tribulations, and formulations in access to new TB drugs for children: learning from rifapentine
AU  - A.C. Hesseling
AU  - N. Salazar-Austin
AU  - M. Louey
AU  - L. van der Laan
AU  - M. Gombe
AU  - T. Masini
AU  - M. Penazzato
AU  - I. Courtney
AU  - A. Garcia-Prats
AU  - D. Tarlton
AU  - M. Frick
PY  - 2026
DA  - 2026/10/01
JO  - IJTLD open
UR  - https://europepmc.org/article/PMC/PMC13657021
SN  - 3005-7590
ER  -